Orange Book product · Generic (ANDA)
KALEXATE
SODIUM POLYSTYRENE SULFONATE
At a glance
Mar 30, 2009
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 30, 2009
17 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM POLYSTYRENE SULFONATE
Strength
454GM/BOT
Dosage form
POWDER
Route
ORAL, RECTAL
TE code
AA
Application
ANDA 040905
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM POLYSTYRENE SULFONATE
- —KAYEXALATEBrand (NDA)
NDA 011287 · CONCORDIA
- 2025SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 214912 · LYNE
- 2016SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 205727 · AJENAT PHARMS
- 2016SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 206815 · CHARTWELL RX
- 2014SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 204071 · NUVO PHARMS INC
- 2014SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 202333 · EPIC PHARMA LLC
- 2011SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 090313 · UPSHER SMITH LABS
- 2011SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 090590 · ANI PHARMS
- 2008SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 040909 · CITRUSPHRMA
- 2007KIONEXGeneric (ANDA)
ANDA 040028 · ANI PHARMS
- 1998KIONEXGeneric (ANDA)
ANDA 040029 · ANI PHARMS
- 1989SODIUM POLYSTYRENE SULFONATEGeneric (ANDA)
ANDA 089910 · CMP PHARMA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
